Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/38361
Full metadata record
DC FieldValueLanguage
dc.contributor.authorQi Q.en
dc.contributor.authorChao Y.en
dc.contributor.authorHill A.en
dc.contributor.authorKang J.en
dc.contributor.authorWang L.en
dc.contributor.authorLi K.en
dc.contributor.authorGan H.en
dc.contributor.authorWu Z.en
dc.contributor.authorYen C.-J.en
dc.contributor.authorMarkman B.en
dc.date.accessioned2021-05-14T13:05:07Zen
dc.date.available2021-05-14T13:05:07Zen
dc.date.copyright2017en
dc.date.created20200303en
dc.date.issued2020-03-03en
dc.identifier.citationAnnals of Oncology. 28 (Supplement 3) (pp iii54), 2017. Date of Publication: June 2017.en
dc.identifier.issn0923-7534en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/38361en
dc.languageenen
dc.publisherElsevier Ltden
dc.relation.ispartofAnnals of Oncologyen
dc.subject.meshresponse evaluation criteria in solid tumors-
dc.subject.meshupper respiratory tract infection-
dc.subject.meshsorafenib-
dc.subject.meshsorafenib/ct-
dc.subject.meshtislelizumab-
dc.subject.meshtislelizumab/ct-
dc.subject.meshadvanced cancer-
dc.subject.meshantineoplastic activity-
dc.subject.meshascites-
dc.subject.meshcancer control-
dc.subject.meshcoughing-
dc.subject.meshdecreased appetite-
dc.subject.meshdrug dose escalation-
dc.subject.meshdrug eruption-
dc.subject.meshdrug fatality-
dc.subject.meshdrug safety-
dc.subject.meshdrug tolerability-
dc.subject.meshfatigue-
dc.subject.meshfever-
dc.subject.meshliver cell carcinoma-
dc.subject.meshphase 1-
dc.titlePreliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC).en
dc.typeArticleen
dc.type.studyortrialClinical trial-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/annonc/mdx261.139-
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid32135938 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32135938]en
dc.identifier.source2005032559en
dc.identifier.institution(Yen) National Cheng Kung University Hospital, Tainan, Taiwan (Republic of China) (Markman) Monash Medical Centre, Clayton, Australia (Chao) Taipei Veterens General Hospital, Taipei City, Taiwan (Republic of China) (Hill) Tasman Oncology Research Ltd., Southport, Australia (Kang, Wang, Li, Qi) BeiGene (Beijing) Co. Ltd., Beijing, China (Wu) BeiGene USA Inc., Fort Lee, New Jersey, United States (Gan) Austin Hospital, Melbourne, Australiaen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
Appears in Collections:Articles
Show simple item record

Page view(s)

20
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.